Financial & Tax Architects’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Financial & Tax Architects's NVS Position: Q2 2026 in Review
Financial & Tax Architects sold out of Novartis (NVS) in Q2 2026, closing a stake of 4,135 shares — an estimated $632K sold.
Financial & Tax Architects first reported a position in NVS in Q1 2021 and held it in 17 quarters. The position peaked at $910K in Q4 2025. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Financial & Tax Architects reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
- Financial & Tax Architects sold 4,135 Novartis shares in Q2 2026, an estimated $632K.
- Financial & Tax Architects first reported a position in Novartis in Q1 2021 and held it in 17 quarters.
- Financial & Tax Architects's Novartis position peaked at $910K in Q4 2025.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Financial & Tax Architects's 13F filing for Q2 2026, filed 23 Jul 2026.